The risk or severity of adverse effects can be increased when Telmisartan is combined with Diclofenac. Telmisartan may increase the hypotensive activities of Unoprostone. Telmisartan may increase the hypotensive activities of Manidipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Naproxen. The risk or severity of adverse effects can be increased when Rotigotine is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Candesartan. Telmisartan may increase the hypotensive activities of Lofexidine. The risk or severity of adverse effects can be increased when Torasemide is combined with Telmisartan. Guanabenz may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Apremilast. The serum concentration of Deslanoside can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Indobufen. The serum concentration of Ouabain can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Esmolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nafamostat. Ketanserin may increase the hypotensive activities of Telmisartan. Iproniazid may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Furosemide is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Tenoxicam. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nabumetone. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nadolol. The risk or severity of adverse effects can be increased when Telmisartan is combined with Tinoridine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Zaltoprofen. The risk or severity of adverse effects can be increased when Telmisartan is combined with Duvelisib. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nifedipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Piroxicam. The risk or severity of adverse effects can be increased when Telmisartan is combined with Bretylium. Telmisartan may increase the hypotensive activities of Epoprostenol. The risk or severity of adverse effects can be increased when Reserpine is combined with Telmisartan. Quinine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Etanercept. The serum concentration of Everolimus can be increased when it is combined with Telmisartan. The serum concentration of Bosutinib can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Dapagliflozin. The risk or severity of adverse effects can be increased when Telmisartan is combined with Mizoribine. Telmisartan may increase the arrhythmogenic activities of Ciprofloxacin. Telmisartan may increase the hypotensive activities of Xylometazoline. Telmisartan may increase the hyperkalemic activities of Cyclosporine. The risk or severity of adverse effects can be increased when Sotalol is combined with Telmisartan. Debrisoquin may increase the hypotensive activities of Telmisartan. Phenoxybenzamine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nepafenac. Telmisartan may increase the hypotensive activities of Cyclopenthiazide. Telmisartan may increase the hypotensive activities of Naftopidil. The serum concentration of Pazopanib can be increased when it is combined with Telmisartan. The serum concentration of Topotecan can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Fosinopril. The risk or severity of adverse effects can be increased when Carbetocin is combined with Telmisartan. The serum concentration of Doxorubicin can be increased when it is combined with Telmisartan. The serum concentration of Acetyldigitoxin can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Bortezomib is combined with Telmisartan. The risk or severity of adverse effects can be increased when Pramipexole is combined with Telmisartan. The risk or severity of adverse effects can be increased when Tretinoin is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Celiprolol. The risk or severity of adverse effects can be increased when Telmisartan is combined with Ibuprofen. Pentoxifylline may increase the hypotensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Efonidipine. Hydracarbazine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Isoxsuprine. Telmisartan may increase the hypotensive activities of Macitentan. Telmisartan may increase the hypotensive activities of Pentolinium. The risk or severity of adverse effects can be increased when Telmisartan is combined with Benazepril. The risk or severity of adverse effects can be increased when Eprosartan is combined with Telmisartan. Safrazine may increase the hypotensive activities of Telmisartan. The serum concentration of Prucalopride can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Felodipine. The risk or severity of adverse effects can be increased when Bumetanide is combined with Telmisartan. Rilmenidine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Benzydamine. The risk or severity of adverse effects can be increased when Pindolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Suprofen. The risk or severity of adverse effects can be increased when Telmisartan is combined with Diclofenamide. The risk or severity of adverse effects can be increased when Telmisartan is combined with E-6201. Lercanidipine may increase the hypotensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Guanethidine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Pirfenidone. The risk or severity of adverse effects can be increased when Telmisartan is combined with Floctafenine. Telmisartan may increase the hypotensive activities of Sitaxentan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Empagliflozin. Telmisartan may increase the hypotensive activities of BQ-123. Telmisartan may increase the hypotensive activities of Niguldipine. Tadalafil may increase the antihypertensive activities of Telmisartan. The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Mycophenolic acid. The risk or severity of adverse effects can be increased when Telmisartan is combined with Oxaprozin. Telmisartan may increase the hypotensive activities of Ferulic acid. Telmisartan may increase the hypotensive activities of Terlipressin. Phenobarbital may increase the hypotensive activities of Telmisartan. The serum concentration of Ranolazine can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Masoprocol. Ardeparin may increase the hyperkalemic activities of Telmisartan. Telmisartan may increase the hypotensive activities of Deserpidine. Tranylcypromine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Felbinac. The risk or severity of adverse effects can be increased when Telmisartan is combined with Indoprofen. The risk or severity of adverse effects can be increased when Nitroprusside is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Zileuton. The risk or severity of adverse effects can be increased when Telmisartan is combined with Carbaspirin calcium. The risk or severity of adverse effects can be increased when Telmisartan is combined with Amyl Nitrite. Trimethoprim may increase the hyperkalemic activities of Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Telmisartan. Indoramin may increase the hypotensive activities of Telmisartan. Fenoldopam may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Telmisartan. Methylphenobarbital may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Quinapril. The risk or severity of adverse effects can be increased when Atenolol is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Bupranolol. The serum concentration of Edoxaban can be increased when it is combined with Telmisartan. Barbexaclone may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Remifentanil is combined with Telmisartan. Hydroflumethiazide may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Triptolide. The risk or severity of adverse effects can be increased when Sufentanil is combined with Telmisartan. Diazoxide may increase the hypotensive activities of Telmisartan. Avanafil may increase the antihypertensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Andrographolide. Telmisartan may increase the hypotensive activities of Lacidipine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nesiritide. Telmisartan may increase the hypotensive activities of Talinolol. Trimazosin may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Flurbiprofen. The risk or severity of adverse effects can be increased when Propranolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Amiloride is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Penbutolol. Pivhydrazine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Dipyridamole. The risk or severity of adverse effects can be increased when Telmisartan is combined with Tolmetin. The risk or severity of adverse effects can be increased when Telmisartan is combined with Pimecrolimus.